〰️
Kyle Vollett was awarded "Top Trainee Abstract -- Cardiac MRI" at the 2024 Annual Meeting of the ISMRM, Singapore (May 2024).
〰️
Congratulations to Keyu Zhuang on winning at the 2024 World Molecular Imaging Congress the "Highest Scoring Abstract from Canada" and representing Canada as "Official Ambassador" (September 2024).
〰️
Congratulations to Keyu Zhuang on her PhD defense (April 2025).
〰️
Congratulations to William Hong on his MASc defense (July 2025).
〰️
Congratulations to Sajida on her OGS scholarship (August 2025).
〰️
Congratulations to Anlan on his Ted Rogers Centre for Heart Research Education Fund award (August 2025).
〰️
Congratulations to Kyle Vollett on his PhD defense (August 2025).
〰️
Congratulations to Aaron Curtis on his PhD defense (August 2025).
〰️ Kyle Vollett was awarded "Top Trainee Abstract -- Cardiac MRI" at the 2024 Annual Meeting of the ISMRM, Singapore (May 2024). 〰️ Congratulations to Keyu Zhuang on winning at the 2024 World Molecular Imaging Congress the "Highest Scoring Abstract from Canada" and representing Canada as "Official Ambassador" (September 2024). 〰️ Congratulations to Keyu Zhuang on her PhD defense (April 2025). 〰️ Congratulations to William Hong on his MASc defense (July 2025). 〰️ Congratulations to Sajida on her OGS scholarship (August 2025). 〰️ Congratulations to Anlan on his Ted Rogers Centre for Heart Research Education Fund award (August 2025). 〰️ Congratulations to Kyle Vollett on his PhD defense (August 2025). 〰️ Congratulations to Aaron Curtis on his PhD defense (August 2025).
ABOUT US
Research in the Cheng laboratory is focused on the development of non-gadolinium contrast agents and quantitative magnetic resonance imaging technology to enable early detection of cardiovascular diseases and to guide new stem cell and tissue engineering therapeutics. We take imaging beyond its role as an anatomical tool and advance it to probe dynamic events at a physiological, cellular, and molecular level. An important philosophy at the heart of our research is translation to patients – hence, our emphasis on faithful animal models of human disease, rapid imaging capabilities, and new contrast agents with a safer toxicity profile than the clinical standard.
